Coblator II System, 120V. Product Usage: The Coblator II (Model RF8000E) is a bipolar, radio...
FDA Device Recall #Z-1323-2015 — Class II — February 20, 2015
Recall Summary
| Recall Number | Z-1323-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 20, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | ArthroCare Medical Corporation |
| Location | Austin, TX |
| Product Type | Devices |
| Quantity | 15 units |
Product Description
Coblator II System, 120V. Product Usage: The Coblator II (Model RF8000E) is a bipolar, radiofrequency electrosurgical system designed for use in otorhinolaryngology (ENT) surgery. The system consists of the following components: an electrosurgical radiofrequency controller, a reusable, non-sterile Power Cord; a reusable, non-sterile Foot Control; a reusable, non-sterile Flow control Valve Unit; a reusable, non-sterile flow control cable; a single use, disposable, sterile Wand. The Coblator II is indicated for ablation, resection, and coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology (ENT) surgery.
Reason for Recall
The recalling firm was notified by the contract manufacturer that they had reversed the L2, L3, L4, or L5 components on the P/N09010 RoHS boards of the Coblator II Controller (Model RF8000E).
Distribution Pattern
US Nationwide Distribution in the states of TN, IA, AZ, NE, SD, NY, and OK.
Lot / Code Information
Serial Numbers: CA0N0000FT, CA0N0000H0, CA0N0000H7, CA0N0000J6, CA0N0000KJ, CA0N0000KK, CA0N0000KL, CA0N0000FW, CA0N0000G5, CA0N0000G6, CA0N0000H1, CA0N0000FR, CA0N0000FZ, CA0N0000KF, CA0N0000GH
Other Recalls from ArthroCare Medical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1832-2015 | Class II | EVAC 70 XTRA with Integrated Cable REF EICA5872... | May 15, 2015 |
| Z-1833-2015 | Class II | PROcise XP Wand with Integrated Cable REF EICA8... | May 15, 2015 |
| Z-0579-2015 | Class II | Model Number ASHA4730-01: Ambient HipVac 50 Wan... | Oct 27, 2014 |
| Z-0652-2014 | Class II | Arthrocare SPORTS MEDICINE, Knot Pusher, REF 25... | Dec 9, 2013 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.